STEMIcathAID

Optimize STEMI Treatment

Beschreibung

STEMIcathAID is a patient recognition, response, and record-keeping system designed to improve outcomes through adherence the American Heart Association’s Mission:Lifeline STEMI guidelines. Early restoration of blood flow to occluded coronary vessels has been shown to significantly improve outcomes for high-risk STEMI patients. STEMIcathAID aims to improve these clinical outcomes by optimizing their treatment following many of the recommendations of the AHA by reducing the time to STEMI recognition, lead acquisition, STEMI identification, notification of the catheterization lab, and reperfusion.

There are multiple personnel and steps involved in caring for these high-risk patients. STEMIcathAID takes an algorithmic approach which will enhance the coordination and communication tasks essential to rapid assessment and easy transfer of STEMI patients from the field or outside facility. It will also provide protocols for the EMS or outside hospital provider to identify patients in cardiogenic shock even before their arrival in the catheterization lab. The application will integrate live GPS tracking of the patients alongside the time the alarm was raised prompting the sense of urgency in transferring the patient.

Incorporating images, videos, illustrations, and live GPS tracking of the EMS, the design will be subdivided into three main sections:

1. EKG Upload by outside facility or EMS
2. Assessment of Cardiogenic Shock
3. STEMI patient transfer pathway

When a medical provider, in the field, other hospital, or outpatient office, suspects STEMI, the provider uploads the EKG by taking a picture of it with their phone. Once the EKG is uploaded, the on-call attending at the PCI-capable facility receives a notification from the application. If the attending believes the patient is experiencing a real STEMI, the pathway is activated. Upon activation, the approximately 10-12 people involved in taking care of the patient are notified so they can begin preparations. Adhering to HIPAA compliance, all users log into the encrypted application and begin to collaborate such aspects as patient vitals, shock information, and emergency vehicle current location and estimated arrival time to the cath lab.

Through the optimized communication and collaboration of multiple key players in the STEMI pathway, these time-critical, vulnerable patients can begin treatment promptly.
Ausblenden Mehr anzeigen...

Screenshots

STEMIcathAID Häufige Fragen

  • Ist STEMIcathAID kostenlos?

    Ja, STEMIcathAID ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist STEMIcathAID seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet STEMIcathAID?

    STEMIcathAID ist kostenlos.

  • Wie hoch ist der Umsatz von STEMIcathAID?

    Um geschätzte Einnahmen der STEMIcathAID-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung

4.33 von 5

3 Bewertungen in Vereinigte Staaten

5 star
2
4 star
0
3 star
0
2 star
0
1 star
0
Bewertungsverlauf

STEMIcathAID Bewertungen

App hat noch keine Bewertungen

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

STEMIcathAID Konkurrenten

Name
Murmur MD
Improving patient outcomes
Cathlas
Coronary Angiography Atlas
OCT-ISR
An educational app for OCT-ISR
PCI App
PCI: opening coronary arteries
Philips Coronary IVUS Tutor
CAMP Edu
N/V
N/V
IVUS + Physiology Pro
Edwards Masters
N/V
N/V

STEMIcathAID Installationen

Letzte 30 Tage

STEMIcathAID Umsatz

Letzte 30 Tage

STEMIcathAID Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von STEMIcathAID mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.

App-Informationen

Kategorie
Medical
Sprachen
English
Letzte Veröffentlichung
1.5.1 (vor 6 Monaten )
Veröffentlicht am
Aug 26, 2020 (vor 4 Jahren )
Auch verfügbar in
Vereinigte Staaten
Zuletzt aktualisiert
vor 3 Monaten
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.